IMRT/Pemetrexed/Cisplatin in Esophageal Cancer

Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer

NCT01670409 ·Status: COMPLETED ·Phase: PHASE2

High Dose PET/CT-guided Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer

NCT03936179 ·Status: UNKNOWN ·Phase: NA

Radiation Dose Study of Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil in Oesophageal Cancer

NCT01646853 ·Status: UNKNOWN ·Phase: NA

Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China

NCT05194371 ·Status: COMPLETED

PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal Cancer

NCT03113214 ·Status: COMPLETED ·Phase: NA

Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma

NCT02429622 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus

NCT03585530 ·Status: UNKNOWN ·Phase: PHASE2

The Application of 3T MRI in Esophageal Cancer

NCT03635619 ·Status: UNKNOWN

IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients

NCT03910634 ·Status: UNKNOWN ·Phase: PHASE2

A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

NCT02459457 ·Status: COMPLETED ·Phase: PHASE3

Paclitaxel or S1 Plus Cisplatin in Concurrent Chemoradiotherapy for Squamous Cell Carcinoma of Esophagus

NCT02586753 ·Status: UNKNOWN ·Phase: PHASE2

Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma

NCT03790553 ·Status: UNKNOWN ·Phase: PHASE3

Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer

NCT07016724 ·Status: RECRUITING ·Phase: PHASE2

Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma

NCT05937438 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer

NCT01732380 ·Status: UNKNOWN ·Phase: PHASE2

A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma

NCT02409186 ·Status: UNKNOWN ·Phase: PHASE3

Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study

NCT07034118 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02

NCT03308552 ·Status: UNKNOWN ·Phase: PHASE3

Chemoradiotherapy in Unresectable Esophageal Cancer

NCT04278287 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

NCT06888531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01

NCT03298204 ·Status: COMPLETED

Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma

NCT06342167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

NCT02858206 ·Status: UNKNOWN ·Phase: PHASE2

A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma

NCT01591135 ·Status: COMPLETED ·Phase: PHASE3

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

NCT02972372 ·Status: RECRUITING ·Phase: NA